BlackRock’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6M | Buy |
3,680,794
+104,586
| +3% | +$359K | ﹤0.01% | 3234 |
|
|
2025
Q1 | $7.97M | Sell |
3,576,208
-520,435
| -13% | -$1.16M | ﹤0.01% | 3393 |
|
|
2024
Q4 | $12M | Buy |
4,096,643
+107,951
| +3% | +$316K | ﹤0.01% | 3289 |
|
|
2024
Q3 | $10.4M | Buy |
3,988,692
+185,215
| +5% | +$482K | ﹤0.01% | 3346 |
|
|
2024
Q2 | $11.3M | Sell |
3,803,477
-97,087
| -2% | -$287K | ﹤0.01% | 3275 |
|
|
2024
Q1 | $17.7M | Sell |
3,900,564
-5,149
| -0.1% | -$23.3K | ﹤0.01% | 3007 |
|
|
2023
Q4 | $22.3M | Buy |
3,905,713
+496,267
| +15% | +$2.83M | ﹤0.01% | 2898 |
|
|
2023
Q3 | $15.7M | Sell |
3,409,446
-41,952
| -1% | -$193K | ﹤0.01% | 3029 |
|
|
2023
Q2 | $22.3M | Sell |
3,451,398
-10,242,897
| -75% | -$66.2M | ﹤0.01% | 2917 |
|
|
2023
Q1 | $103M | Sell |
13,694,295
-157,707
| -1% | -$1.19M | ﹤0.01% | 1977 |
|
|
2022
Q4 | $140M | Buy |
13,852,002
+1,282,862
| +10% | +$13M | ﹤0.01% | 1769 |
|
|
2022
Q3 | $124M | Buy |
12,569,140
+743,808
| +6% | +$7.36M | ﹤0.01% | 1808 |
|
|
2022
Q2 | $126M | Buy |
11,825,332
+9,378,033
| +383% | +$99.9M | ﹤0.01% | 1857 |
|
|
2022
Q1 | $23.9M | Buy |
2,447,299
+80,057
| +3% | +$781K | ﹤0.01% | 2995 |
|
|
2021
Q4 | $33.9M | Buy |
2,367,242
+1,390,655
| +142% | +$19.9M | ﹤0.01% | 2890 |
|
|
2021
Q3 | $19.6M | Buy |
976,587
+79,400
| +9% | +$1.59M | ﹤0.01% | 3239 |
|
|
2021
Q2 | $19.7M | Buy |
897,187
+41,714
| +5% | +$918K | ﹤0.01% | 3262 |
|
|
2021
Q1 | $29.1M | Buy |
855,473
+505,056
| +144% | +$17.2M | ﹤0.01% | 2925 |
|
|
2020
Q4 | $14.1M | Buy |
+350,417
| New | +$14.1M | ﹤0.01% | 3126 |
|